
The Board of Directors of DRAXIS Health Inc. believes that sound corporate governance practices are essential to the well-being of the Company and its shareholders, and that these practices should be reviewed regularly to ensure that they are appropriate. The Board has carefully considered and reviewed the series of guidelines for effective corporate governance issued by The Toronto Stock Exchange (the "TSX Guidelines"), the corporate governance requirements of the U.S. Sarbanes-Oxley Act of 2002 (the "SOX Requirements") and the corporate governance reforms of the NASDAQ Stockmarket, Inc. (the "NASDAQ Rules"). The Board of Directors believes that the Company's corporate governance practices satisfy the recommendations and rules contained in these various guidelines and regulations. The Board of Directors is also reviewing the proposed corporate governance reforms contained in Multilateral Policy 58-201 entitled "Effective Corporate Governance" recently proposed by the Canadian securities regulators.
The mandate of the Board of Directors is to supervise the management of the business and affairs of the Company. In light of that responsibility, the Board of Directors reviews, discusses and approves various matters related to the Company's operations, strategic direction and organizational structure where required and involves itself jointly with management in ensuring the creation of shareholder value and in serving the best interests of the Company. In April 2004, the Board of Directors adopted a detailed Charter. The Charter specifies that the Board of Directors is responsible for:
In April 2004, the Board of Directors adopted detailed Charters for the Board of Directors and its Committees.
Charter of the Board of Directors
Charter of the Audit Committee